Reply to: Cognitive Safety of Cannabis Products in Parkinson’s Disease: Need for Solid Scientific Evidence to Guide Clinicians and Patients Currently on Shaky Grounds

Mov Disord. 2024 Jan;39(1):222-223. doi: 10.1002/mds.29667.

NO ABSTRACT

PMID:38294047 | DOI:10.1002/mds.29667